Viking Therapeutics, Inc. (VKTX) › Shares OutstandingViking Therapeutics, Inc. (VKTX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2014: 6.00M2015: 9.68M2016: 20.82M2017: 35.82M2018: 71.74M2019: 72.41M2020: 73.22M2021: 78.25M2022: 78.26M2023: 100.11M2024: 111.57M2025: 114.79M114.79M2014Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025114.79M+2.9%2024111.57M+11.4%2023100.11M+27.9%202278.26M+0.0%202178.25M+6.9%202073.22M+1.1%201972.41M+0.9%201871.74M+100.3%201735.82M+72.0%201620.82M+115.0%20159.68M+61.4%20146.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share